Shire
Article Abstract:
Shire Pharmaceuticals is to merge with BioChem Pharma, and the company's performance is examined in detail.
Publisher: FT Business
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 2001
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
Elan
Article Abstract:
Elan has been aided by strong sales of some new drugs, and the company's sales force has been restructured.
Publisher: FT Business
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 2001
Elan
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
A quip too far
Article Abstract:
The performance of Shire Pharmaceuticals and its chief executive, Rolf Stahel, are examined in detail.
Publisher: FT Business
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 2001
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: Management, Pharmaceutical industry, Drugs, Shire Pharmaceuticals Group PLC
Similar abstracts:
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.